113 related articles for article (PubMed ID: 35802475)
1. Progress in the quality of care for newly diagnosed people with HIV in Spain (2004-2019).
Alejos B; Díez C; Galindo MJ; López JC; Moreno-García E; Estrada V; Poveda E; Omar M; Jarrín I; Berenguer J;
Antivir Ther; 2022 Aug; 27(4):13596535221112729. PubMed ID: 35802475
[TBL] [Abstract][Full Text] [Related]
2. Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.
Hernando V; Cuevas MT; Pérez-Olmeda MT; Tasias M; Vera M; Jaen A; Mena A; Jarrin I; Diaz A;
Infect Dis (Lond); 2021 Jun; 53(6):440-449. PubMed ID: 33685324
[TBL] [Abstract][Full Text] [Related]
3. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
Serrano-Villar S; Martínez-Sanz J; Ron R; Talavera-Rodríguez A; Fernández-Felix BM; Herrera S; Muriel A; Fanjul F; Portilla J; Muñoz J; Amador C; de Zárraga MA; Vivancos MJ; Moreno S;
Lancet HIV; 2020 Aug; 7(8):e565-e573. PubMed ID: 32763219
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and Clinical Profile of Newly Diagnosed HIV/AIDS Patients: A Retrospective Analysis of Changing Trends Over 16 Years.
Zerdali E; Nakir IY; Sayili U; Sürme S; Yildırım M
Curr HIV Res; 2023; 21(1):35-42. PubMed ID: 36631925
[TBL] [Abstract][Full Text] [Related]
5. Life expectancy of people with HIV on antiretroviral therapy in Spain.
Jarrín I; Rava M; Del Romero Raposo J; Rivero A; Del Romero Guerrero J; De Lagarde M; Martínez Sanz J; Navarro G; Dalmau D; Blanco JR; Koerting A; Gomez Castell J; Del Amo J;
AIDS; 2024 Mar; 38(3):387-395. PubMed ID: 37905999
[TBL] [Abstract][Full Text] [Related]
6. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.
Jarrin I; Suarez-Garcia I; Moreno C; Tasias M; Del Romero J; Palacios R; Peraire J; Gorgolas M; Moreno S;
Antivir Ther; 2019; 24(3):167-175. PubMed ID: 30747107
[TBL] [Abstract][Full Text] [Related]
7. Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08).
Romero A; González V; Esteve A; Martró E; Matas L; Tural C; Pumarola T; Casanova A; Ferrer E; Caballero E; Ribera E; Margall N; Domingo P; Farré J; Puig T; Sauca MG; Barrufet P; Amengual MJ; Navarro G; Navarro M; Vilaró J; Ortín X; Ortí A; Pujol F; Prat JM; Massabeu A; Simó JM; Villaverde CA; Benítez MÁ; Garcia I; Díaz O; Becerra J; Ros R; Sala R; Rodrigo I; Miró JM; Casabona J;
Eur J Public Health; 2012 Dec; 22(6):802-8. PubMed ID: 22158995
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand.
Thitipatarakorn S; Chinbunchorn T; Peelay J; Seekaew P; Amatavete S; Sangsai M; Pankam T; Avihingsanon A; Avery M; Phanuphak P; Ramautarsing R; Phanuphak N
BMC Public Health; 2022 Jan; 22(1):144. PubMed ID: 35057784
[TBL] [Abstract][Full Text] [Related]
9. The shifting picture of HIV treatment, comorbidity and substance use among US MSM living with HIV.
D'Souza G; Benning L; Stosor V; Witt MD; Johnson J; Friedman M; Abraham AG
HIV Med; 2021 Aug; 22(7):538-546. PubMed ID: 33751813
[TBL] [Abstract][Full Text] [Related]
10. Country of birth is associated with antiretroviral therapy choice in treatment-naive persons with HIV in France.
Palich R; Hentzien M; Hocqueloux L; Duvivier C; Allavena C; Huleux T; Delobel P; Makinson A; Rey D; Cuzin L;
AIDS; 2023 Jul; 37(9):1459-1466. PubMed ID: 37115905
[TBL] [Abstract][Full Text] [Related]
11. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.
Gianotti N; Lorenzini P; Cozzi-Lepri A; De Luca A; Madeddu G; Sighinolfi L; Pinnetti C; Santoro C; Meraviglia P; Mussini C; Antinori A; d'Arminio Monforte A;
J Antimicrob Chemother; 2019 Sep; 74(9):2732-2741. PubMed ID: 31173639
[TBL] [Abstract][Full Text] [Related]
12. Immune profile at HIV infection diagnosis: Evolution in the French Alps area over the last 20 years.
Gueneau R; Dufresne S; Valran A; Janssen C; Leclercq P; Epaulard O
Med Mal Infect; 2020 Aug; 50(5):428-432. PubMed ID: 31757516
[TBL] [Abstract][Full Text] [Related]
13. Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study.
García-Ruiz de Morales AG; Vivancos MJ; de Lagarde M; Ramírez Schacke M; Del Mar Arcos Rueda M; Orviz E; Curran A; Carmona-Torre F; Moreno S; Pérez-Elías MJ; Martínez-Sanz J;
Lancet HIV; 2024 Jul; 11(7):e470-e478. PubMed ID: 38824937
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
15. Demographics of Youth With Newly Diagnosed Acute/Recent HIV Infection in Adolescent Trials Network 147: Early Treatment of Acute HIV Infection.
Kerin T; Cortado R; Paiola SG; Ceballos J; Abdalian SE; Flynn R; Bolan R; Adebambo YV; Sim MS; Swendeman D; Ocasio MA; Fournier J; Ank B; Bryson Y; Nielsen-Saines K
J Adolesc Health; 2024 Mar; 74(3):573-581. PubMed ID: 38043041
[TBL] [Abstract][Full Text] [Related]
16. [Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].
Caro-Murillo AM; Castilla J; Pérez-Hoyos S; Miró JM; Podzamczer D; Rubio R; Riera M; Viciana P; López Aldeguer J; Iribarren JA; de los Santos-Gil I; Gómez-Sirvent JL; Berenguer J; Gutiérrez F; Saumoy M; Segura F; Soriano V; Peña A; Pulido F; Oteo JA; Leal M; Casabona J; del Amo J; Moreno S;
Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):23-31. PubMed ID: 17261243
[TBL] [Abstract][Full Text] [Related]
17. [HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].
Caro-Murillo AM; Gutiérrez F; Manuel Ramos J; Sobrino P; Miró JM; López-Cortés LF; Tural C; Moreno A; de Los Santos I; Murillas J; Camino X; Salavert M; Rubio R; Moreno S; del Amo J;
Enferm Infecc Microbiol Clin; 2009; 27(7):380-8. PubMed ID: 19427080
[TBL] [Abstract][Full Text] [Related]
18. Partnership status and time to viral suppression and sustained viral suppression among newly diagnosed heterosexual people with HIV.
Sohail M; Long DM; Batey DS; Mugavero MJ; Ojesina AI; Levitan EB
Int J STD AIDS; 2022 Mar; 33(4):347-354. PubMed ID: 35085052
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study.
Díez C; Del Romero-Raposo J; Mican R; López JC; Blanco JR; Calzado S; Samperiz G; Portilla J; García-Fraile LJ; Gutiérrez F; Gómez-Sirvent JL; Suárez-García I; Amador C; Novella M; Arribas JR; Moreno S; González-García J; Jarrín I; Berenguer J;
HIV Med; 2021 Oct; 22(9):867-876. PubMed ID: 34324783
[TBL] [Abstract][Full Text] [Related]
20. Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population.
Reyes-Urueña JM; Campbell CNJ; Vives N; Esteve A; Ambrosioni J; Tural C; Ferrer E; Navarro G; Force L; García I; Masabeu À; Vilaró JM; García de Olalla P; Caylà JA; Miró JM; Casabona J;
BMJ Open; 2018 Feb; 8(2):e018533. PubMed ID: 29490955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
